Adamax
Also known as: Adamantyl-Semax
Overview
Enhanced Semax analog with an adamantane group addition. Exhibits superior BDNF upregulation compared to original Semax, with greater nootropic and neuroprotective potency. Improves cognitive function, focus, and memory.
Modified peptide — Semax analog with adamantane group conjugated to the N-terminus
Half-life
~4-6 hours
Administration Route
Intranasal or subcutaneous
Category
Cognitive & Neuroprotective
Mechanism of Action
- Enhanced BDNF upregulation (superior to Semax)
- Neuroprotection and neuronal survival support
- Nootropic effect with improved focus, memory, and learning
- Neurotransmitter modulation (dopamine, serotonin)
- Anti-inflammatory action in the central nervous system
Dosage Protocol
Data compiled from the literature. This does not constitute medical advice.
| Parameter | Value |
|---|---|
| Dose | 100-500 mcg via intranasal or subcutaneous |
| Frequency | 1-2 times daily |
| Timing | Morning and/or early afternoon |
| Duration | 2-4 weeks |
Reported Side Effects
Adverse effects described in the literature. Severity and frequency vary between individuals.
- Mild headache
- Nasal irritation
- Insomnia (if used at night)
Presentations & Preparation
Vials of Adamax found in the research market:
Reconstitution
- Diluent: Bacteriostatic water
- Volume: 2 ml per vial
- Inject the diluent slowly against the vial wall
- Gently swirl until fully dissolved
- Also available in nasal formulation (spray)
Storage
- Lyophilized: Refrigerated 2-8°C
- Reconstituted: Refrigerated 2-8°C (up to 30 days)
- Protect from direct light
- Do not freeze after reconstitution
Related Peptides
Cerebrolysin
5-30 ml per injection · Once daily
Cortagen
5-10 mg per day via subcutaneous injection · Once daily
Dihexa
10-20 mg per subcutaneous injection or oral (research) · Once daily
DSIP
100-300 mcg per subcutaneous injection · Once daily
Epithalon
5-10 mg per injection · Once daily or every other day
FG Loop
5-10 mg per subcutaneous injection · Once daily or every other day